Angiodynamic Profit Margin

Angiodynamic (ANGO) currently reports a profit margin of -10.12% as of August 2026. That compares with -10.67% in the prior-year period — up 5.2% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore Angiodynamic's profit margin history and peer comparisons.

Angiodynamic's profit margin increased from -10.67% to -10.12% — a 5.2% year-over-year increase (period ending August 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Angiodynamic's profit margin of -10.12% is lower than the Healthcare sector average of 10.58%. That is roughly 195.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Angiodynamic's current -10.12% should be judged against Healthcare norms (sector average: 10.58%) and against ANGO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -10.12%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Angiodynamic, and consider following ANGO for alerts when major investors trade the stock.